Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography, and the nuclear imaging modalities of PET and SPECT.

TAVR, other interventional procedures may provide value for patients with carcinoid heart disease
These patients are typically treated with surgery, but those procedures carry their own risks that clinicians would prefer to avoid.
Cardiovascular health societies share new performance and quality measures for PAD management
The ACC and AHA have published updated performance and quality measures focused on the diagnosis and management of peripheral artery disease. Several other specialty societies, including SCAI and SIR, also participated in the development of this new document.
Health insurer Highmark will provide 100% coverage for all diagnostic breast imaging
The new policy applies to all health plans across Pennsylvania, New York, West Virginia and Delaware, “removing financial barriers for essential breast cancer diagnostics.”
CCTA continues to transform cardiac imaging, interventional cardiology
Mirvat Alasnag, MD, spoke to Cardiovascular Business about CCTA's growing influence in cardiology.
Hologic issues safety alert for breast biopsy needles
The safety notice was issued due to the risk of pieces of the needles dislodging into tissue during procedures.

Breast imaging with both FDG PET and MR provides additional information

Pretreatment PET with F-18 FDG as well as MR imaging provides useful diagnostic data, with PET showing a particular edge for prognosis, according to a study published online March 24 in the Journal of Nuclear Medicine.

Lantheus Medical Imaging implicated in $6.2M tax settlement

The office of the New York attorney general, Eric T. Scheiderman, released a statement earlier this month naming Lantheus Medical Imaging and Bristol-Myers Squib in a $6.2 million settlement for failing to pay corporate income taxes in New York.

PET points to neuroinflammation in chronic fatigue syndrome

The symptoms experienced by those who suffer from chronic fatigue may be related to acute inflammation in the brain, according to a PET study published March 24 in the Journal of Nuclear Medicine.

Global radiopharmaceutical market experiencing significant growth

The worldwide market for radiopharmaceuticals is expected to round out at a compound annual growth rate of 18.39 percent every year from 2012 through 2016, according to a report announced March 26 by research firm TechNavio.

NeuroPhage gets $17M boost for brain therapeutics

Pharmaceutical company NeuroPhage has nailed $15 million in financing for therapeutic drugs for neurodegenerative disorders including Alzheimer’s disease and Parkinson's, the company announced March 25.

Type two diabetes definitively leads to neuronal injury, but the jury is still out whether it contributes to the buildup of beta-amyloid in the brain associated with Alzheimer’s disease, according to a study published March 20 by the Journal of Nuclear Medicine.

MPI mysteriously down 51% across a Kaiser health system

A community-wide evaluation of myocardial perfusion imaging (MPI) use throughout the Kaiser Permanente Northern California health system revealed an unexplainable 51 percent dip in MPI from 2006-2011, according to research published today in the Journal of the American Medical Association.

MITA names new PET policy director

The Medical Imaging and Technology Alliance (MITA) has brought in Terri Wilson as the organization’s director of PET industry policy.

Medical Imaging

TAVR, other interventional procedures may provide value for patients with carcinoid heart disease

Cardiovascular health societies share new performance and quality measures for PAD management

Health insurer Highmark will provide 100% coverage for all diagnostic breast imaging

CCTA continues to transform cardiac imaging, interventional cardiology

Hologic issues safety alert for breast biopsy needles